Edmund A. Pribitkin MD

Summary

• Dr. Pribitkin is an Executive Vice President at Jefferson Health, Philadelphia’s fastest growing provider of health care services with 31 hospitals and over 200 outpatient and urgent care locations accounting for more than 3.8 million annual visits. He leads the Jefferson Medical Group, which is comprised of over 6500 employed physicians and advanced practice providers.
  
  During his quarter century at Jefferson, Dr. Pribitkin has served as a residency program director, academic vice chair, President of Jefferson University Physicians and the Chief Medical Officer for Thomas Jefferson University Hospital. A recipient of the Jefferson Career Achievement in Medicine Award and the Dean’s Outstanding Clinician Award, Dr. Pribitkin is regularly listed as one of Philadelphia’s Top Docs by Philadelphia magazine and one of America’s Top Docs by Castle & Connolly. Dr. Pribitkin is a professor at Thomas Jefferson University, where he co-founded the Jefferson Thyroid and Parathyroid Center, the first multi-disciplinary center of its kind in the region. He authored the world’s first Botox Cosmetic dose response study, originated Sonic rhinoplasty and invented an epinephrine delivery device attached to a smartphone. He received his medical degree from the Perelman Medical School at the University of Pennsylvania and his MBA from The Wharton School.